Table 1 Baseline characteristics
Characteristic | Total patients (N = 2,200) |
|---|---|
Mean age, mean (SD), years | 69.3 (9.9) |
Age category, n (%), years | |
 40–59 | 414 (18.8) |
 60–64 | 268 (12.2) |
 65–74 | 824 (37.5) |
 75–84 | 576 (26.2) |
  ≥ 85 | 118 (5.4) |
Female, n (%) | 1,098 (49.9) |
Insurance type, n (%) | |
 Commercial | 666 (30.3) |
 Medicare Advantage | 1,534 (69.7) |
Charlson comorbidity score, mean (SD) | 1.5 (1.5) |
Baseline (6Â month) COPD exacerbations, mean (SD) | 0.7 (0.9) |
 Severe | 0.1 (0.4) |
 Moderate | 0.6 (0.8) |
Comorbidities, n (%) | |
 COPD and bronchiectasis | 2,154 (97.9) |
 Hypertension | 1,417 (64.4) |
 Other lower respiratory disease | 1,353 (61.5) |
 Disorders of lipid metabolism | 1,215 (55.2) |
 Asthma | 380 (17.3) |
Baseline maintenance therapy use, n (%) | |
 LAMA | 624 (28.4) |
 ICS | 138 (6.3) |
 ICS/LABA | 584 (26.6) |
Baseline respiratory medication use, n (%) | |
 OCS | 836 (38.0) |
 SABA | 899 (40.9) |
 SAMA | 65 (3.0) |
 SAMA/SABA | 252 (11.5) |